Target intelligence / Profile preview

Alpha-chymotrypsin (α-Chymotrypsin)

Target
α-Chymotrypsin
Molecular classification
Enzyme, Serine protease, Peptidase S1 family, PA clan of proteases
01

Overview

Alpha-chymotrypsin is a serine protease enzyme produced in the pancreas as an inactive precursor (chymotrypsinogen) and activated in the duodenum by trypsin cleavage. It catalyzes the hydrolysis of peptide bonds on the carboxyl side of large hydrophobic amino acids such as phenylalanine, tryptophan, and tyrosine, playing a critical role in protein digestion. Structurally, it is characterized by three peptide chains held together by disulfide bonds and a catalytic triad (serine, histidine, aspartate) that orchestrates nucleophilic attack on peptide substrates. Besides its digestive role, alpha-chymotrypsin is used therapeutically as an anti-inflammatory and proteolytic agent in surgery, particularly ophthalmic procedures. Loss of enzyme activity can occur due to denaturation from heat or pH changes, and allergic or irritant reactions may rarely limit its clinical use[1][2][3][4][5][7].

Other names
ChymotrypsinChymotrypsin AChymotrypsin BChymarAlpha-chymarChymotestQuimarQuimotraseEnzeonOphthAvazymeα-Chy
02

Mechanism of action

Proteolytic cleavage of peptide bonds C-terminal to aromatic amino acids (tyrosine, tryptophan, phenylalanine) in proteins and polypeptides, via a covalent hydrolysis (ping-pong) mechanism involving a catalytic triad (Ser195, His57, Asp102)[1][2][3][5]

03

Biological functions

Proteolysis (breakdown of proteins and polypeptides)Digestion in the small intestineActivation of digestive enzyme cascades
04

Disease associations

Other (used as a therapeutic enzyme and in surgery)Inflammation (rarely, when used externally)Infection (adjunct use in ophthalmologic surgery)
05

Safety considerations

Allergic reactions (rare, in some patients upon administration)Potential for local tissue irritationinstability at extremes of pH or temperatureloss of enzyme activity due to denaturation at high temperature or improper storage[4][6][7]
06

Interacting drugs

None as direct inhibitors used therapeutically; chymotrypsin itself is used as a therapeutic enzyme[7]
07

Biomarkers

None commonly used for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Alpha-chymotrypsin (α-Chymotrypsin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-chymotrypsin (α-Chymotrypsin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call